PEREGRINE CAPITAL MANAGEMENT LLC Blueprint Medicines Corporation Transaction History

PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:

$7.39M
portfolio value

PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:

+30.45%
quarter

Blueprint Medicines Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -15.33% -20.33K shares 700K $65.89 112.28K
Q2 2022 share Increase +4.53% 5.75K shares -1.40M $50.51 132.62K
Q1 2022 share Increase +2.59% 3.19K shares -5.14M $63.88 126.86K
Q4 2021 share Increase +2.91% 3.5K shares 891K $109.45 123.66K
Q3 2021 share Decrease -24.70% -39.41K shares -1.68M $102.81 120.16K
Q2 2021 share Increase +5.61% 8.47K shares -656K $87.96 159.58K
Q1 2021 share Decrease -12.25% -21.08K shares -4.61M $97.23 151.11K
Q4 2020 share Decrease -8.33% -15.65K shares 1.89M $112.15 172.19K
Q3 2020 share Increase +10.43% 17.74K shares 4.14M $92.7 187.84K
Q2 2020 share Decrease -14.29% -28.36K shares 1.66M $78 170.10K
Q1 2020 share Increase 0.00% 198.46K shares 11.60M $58.48 198.46K